drugset

drugset / Trial / NCT02484482

Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)

NCT02484482 ↗

Phase 1 Completed 45 enrolled Chong Kun Dang Pharmaceutical

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose this study investigate the effect of food on the pharmacokinetics/pharmacodynamics and safety of CKD-519

Timeline

Start: 2015-06
Primary completion: 2015-08
Completion: 2015-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ROCACETRAPIB	Small molecule	200 mg	Oral

Indications